GAMMA Investing’s Voyager Therapeutics VYGR Stock Holding History

GAMMA Investing’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.97K	Buy	736 +564	+328%	+$1.82K	﹤0.01%	3957
2026 Q2	$602	Sell	172 -187	-52%	-$709	﹤0.01%	3961
2026 Q1	$1.39K	Buy	+359	New	+$1.41K	﹤0.01%	3763
2025 Q2	–	Sell	-50	Closed	-$169	–	3896
2025 Q1	$169	Sell	50 -65	-57%	-$304	﹤0.01%	3762
2024 Q4	$652	Sell	115 -33	-22%	-$213	﹤0.01%	3528
2024 Q3	$866	Sell	148 -40	-21%	-$291	﹤0.01%	3295
2024 Q2	$1.49K	Sell	188 -11	-6%	-$92	﹤0.01%	2963
2024 Q1	$1.85K	Buy	199 +50	+34%	+$422	﹤0.01%	2768
2023 Q4	$1.08K	Buy	+149	New	+$1.08K	﹤0.01%	2764

Other funds holding VYGR

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's VYGR Position: Q3 2026 in Review

GAMMA Investing increased its Voyager Therapeutics (VYGR) stake by 328% in Q3 2026, buying an estimated $1.82K and bringing the position to 736 shares worth $1.97K. The position accounts for ﹤0.01% of the portfolio, ranked #3957.

GAMMA Investing first reported a position in VYGR in Q4 2023 and has held it in 9 quarters since. 2 funds tracked by Wall St. Rank hold VYGR as of Q3 2026.

GAMMA Investing held 736 shares of Voyager Therapeutics worth $1.97K as of Q3 2026.
GAMMA Investing bought 564 Voyager Therapeutics shares in Q3 2026, an estimated $1.82K.
Voyager Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3957 holding.
GAMMA Investing first reported a position in Voyager Therapeutics in Q4 2023 and has held it in 9 quarters since.
2 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.